A biotech company founded by Johns Hopkins researchers to develop new drugs to fight cancer said this week that it is raising $40 million in Series A funding.
The round for Dracen Pharmaceuticals was led by Deerfield Management Company, a New York–based firm which invested $36 million in the round.
The year-old company is building on discoveries by Johns Hopkins professors Barbara Slusher, Jonathan Powell and Rana Rais, as well as Pavel Majer of the Institute of Organic Chemistry and Biochemistry in Prague.
The research has shown initial effectiveness of “immuno-metabolism.” According to the company, this involves fighting cancer on two fronts at the same time. One element is cancer metabolism, which seeks to stop the energy sources that keep tumors alive. The other is immunotherapy, which involves harnessing the body’s own immune system to fight cancer.
The company is looking to develop a pipeline of drugs that build on this work, and also sees potential to extend to other types of diseases. The funding will help advance that work.
“Deerfield’s engagement in our efforts helps bring us closer to an important potential step forward in the treatment of cancer,” Dracen CEO Thomas M. Etsok said in a statement.
It’s just the latest recent sign of interest in work at Johns Hopkins from healthcare-focused Deerfield. Separately, the firm is also backing a joint venture with Johns Hopkins for early stage therapeutic research called Bluefield Innovations. That fund has $65 million available for research work that shows promise toward being commercialized.
It’s one happening among the university’s wider effort to create more companies from research efforts that once again set the nationwide pace in spending.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
3 ways to support our work:- Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
- Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
- Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!